Royal Bank Of Canada Cuts Molina Healthcare (NYSE:MOH) Price Target to $218.00

Molina Healthcare (NYSE:MOH) had its price target lowered by Royal Bank Of Canada from $248.00 to $218.00 in a report issued on Friday, MarketBeat Ratings reports. Royal Bank Of Canada currently has a sector perform rating on the stock.

A number of other analysts have also recently commented on the company. Jefferies Financial Group set a $230.00 price target on Molina Healthcare in a research report on Tuesday, July 14th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Molina Healthcare in a research report on Friday. JPMorgan Chase & Co. lifted their price objective on Molina Healthcare from $169.00 to $191.00 and gave the company a “neutral” rating in a research note on Monday, June 8th. Robert W. Baird boosted their target price on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a research note on Friday, April 24th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Molina Healthcare presently has an average rating of “Hold” and a consensus target price of $203.38.

Molina Healthcare Trading Up 0.0%

Shares of NYSE MOH opened at $197.64 on Friday. Molina Healthcare has a 1 year low of $121.06 and a 1 year high of $244.89. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68. The firm has a 50-day moving average of $206.19 and a 200 day moving average of $176.97. The stock has a market cap of $10.32 billion, a P/E ratio of -1,097.94 and a beta of 0.74.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The business had revenue of $10.87 billion for the quarter, compared to analysts’ expectations of $10.83 billion. During the same quarter in the prior year, the company earned $5.48 earnings per share. The business’s revenue was down 4.8% compared to the same quarter last year. As a group, sell-side analysts expect that Molina Healthcare will post 5.31 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In related news, CAO Maurice Hebert sold 600 shares of the stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by insiders.

Hedge Funds Weigh In On Molina Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. AQR Capital Management LLC raised its holdings in shares of Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after purchasing an additional 2,008,458 shares during the last quarter. 8 Knots Management LLC bought a new position in Molina Healthcare during the fourth quarter valued at approximately $198,942,000. Maverick Capital Ltd. purchased a new stake in Molina Healthcare in the first quarter worth approximately $86,081,000. Madison Avenue Partners LP purchased a new stake in Molina Healthcare in the fourth quarter worth approximately $110,003,000. Finally, Norges Bank bought a new stake in Molina Healthcare in the 4th quarter worth approximately $109,766,000. Institutional investors own 98.50% of the company’s stock.

More Molina Healthcare News

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Molina Healthcare beat Q2 earnings expectations with EPS of $1.51, and lower operating expenses helped offset weaker premium revenue and softer investment income. The company also raised its 2026 EPS outlook, which supports the long-term earnings case. Article Title
• Positive Sentiment: Analysts still see some upside from current levels despite recent weakness, with Truist and RBC both saying the stock could rise into the low-to-mid $200s. Article Title
• Neutral Sentiment: Wall Street’s consensus recommendation remains “Hold,” suggesting analysts are not turning bullish yet, but are also not broadly negative on the name. Article Title
• Negative Sentiment: Revenue and membership trends remain a concern, and multiple reports said investors were disappointed by weaker premium revenue and softer guidance even after the earnings beat. Article Title
• Negative Sentiment: Market reaction has been negative because Molina warned about a smaller Obamacare footprint and ongoing pressure in its Medicaid/ACA businesses, which outweighed the earnings beat. Article Title

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.